Mancini Anthony, Chief Global Commercialization Officer exercised 9,363 shares of Revolution Medicines, Inc. ($RVMD) @ $33.62 ($314,784.06 total) on Sep 10, 2026

Mancini Anthony – Chief Global Commercialization Officer

Sep 10, 2026

52W Low$45.60

Current$205.8989.7% above low, 10.3% below high

Purchase$33.62-6.7% above low, 106.7% below high

52W High$224.31

9,363

Price

$33.62

Total Value

$314,784.06

Nearby Earnings

No earnings within 2 weeks of this transaction.

Insider	Mancini Anthony
Title	Chief Global Commercialization Officer
Transaction Date	Sep 10, 2026
Transaction Code	M Exercise/Conversion
Acquired/Disposed	Acquired
Security	Common Stock
Direct/Indirect	Direct
Filing Date	Sep 14, 2026
Shares Purchased	9,363
Price per Share	$33.62
Total Value	$314,784.06
Shares Owned After	59,338
Derivative	No
Accession Number	0002124509-26-000004
Document	View SEC Filing